Description

Enlimomab Pegol is a PEGylated monoclonal antibody fragment designed for targeted therapeutic intervention. This engineered biologic offers enhanced stability and prolonged circulation time, making it a critical component for advanced pharmaceutical research and development. It is primarily utilized by biotechnology firms and pharmaceutical companies engaged in the creation of novel treatments for inflammatory and autoimmune conditions.

Application

• Pharmaceutical R&D: Serves as a key active pharmaceutical ingredient (API) or intermediate in the development of targeted biologic therapies.
• Immunology Research: Used as a research tool to study cell adhesion molecules and inflammatory pathways in preclinical models.
• Bioconjugation Studies: Acts as a model compound for developing and optimizing PEGylation techniques to improve drug pharmacokinetics.
• Reference Standard: Employed as a high-purity analytical standard for quality control and assay validation in biopharmaceutical manufacturing.

Basic Information

Product Name	Enlimomab Pegol
CAS No.	169802-84-0
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	PEG-Enlimomab; Enlimomab-PEG; Anti-ICAM-1 Fab'-PEG; CD54 Antibody Fragment Pegylated; Enlimomab Pegol (USAN); Pegylated Enlimomab Fab' Fragment; Hu23F2G-PEG
EINECS	Contact for details

Quality Control

Our Enlimomab Pegol is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including purity assessment by HPLC, identity confirmation, and biological activity assays to ensure it meets rigorous standards for research and development use. Certificates of Analysis (COA) with full traceability are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below. This product is hygroscopic (moisture-sensitive) and should be handled under controlled, dry conditions to maintain stability. For long-term storage, keep desiccated.

Specification

Item	Specification
Appearance	White to off-white lyophilized powder or solid
Identification (HPLC/MS)	Conforms to reference standard
Purity (HPLC)	≥ 95.0%
Protein Content	≥ 90%
PEG Content	As per theoretical calculation
Biological Activity (Binding Assay)	Conforms to reference
Endotoxin	< 10 EU/mg
Moisture (KF)	< 5.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.